| 11-oxygenated androgens as biomarkers in congenital adrenal hyperplasia: reference intervals for children BPH Adriaansen, S Oude-Alink, DW Swinkels, MAM Schroder, PN Span, ... HORMONE RESEARCH IN PAEDIATRICS 96, 150-151, 2023 | | 2023 |
| 132 oral EXPRESSION OF THE EPIDERMAL GROWTH FACTOR PREDICTS THE EFFECT OF HYPOXIA MODIFICATION AS AN ADDITIVE TO ACCELERATED RADIOTHERAPY OF LARYNGEAL CANCER IN A RANDOMIZED TRIAL M Nijkamp, P Span, I Hoogsteen, C Terhaard, P Doornaert, H Langendijk, ... Radiotherapy and Oncology, S49, 2011 | | 2011 |
| 18F-FLT PET during radiotherapy or BAW Hoeben, EGC Troost, PN Span, CML van Herpen, J Bussink, ... PET imaging for characterization of head and neck tumors 54 (4), 149, 2013 | | 2013 |
| 18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome BAW Hoeben, EGC Troost, PN Span, CML van Herpen, J Bussink, ... Journal of Nuclear Medicine 54 (4), 532-540, 2013 | 140 | 2013 |
| 246 The castration-resistant prostate cancer-associated miRNAs, miR-3687 and miR-4417, are involved in tumour cell hypoxia response and tumour cell migration S Fussek, C Rönnau, PN Span, M Burchardt, GW Verhaegh, JA Schalken European Urology Supplements 3 (15), e246, 2016 | 2 | 2016 |
| 3a—Hydroxysteroid Oxidoreductase Activities in Dihydrotestosterone Degradation and PN Span, CGJ Sweep, TJ Benraad, AGH Smals | | 1996 |
| 3α-Hydroxysteroid oxidoreductase activities in dihydrotestosterone degradation and back-formation in rat prostate and epididymis PN Span, CGJ Sweep, TJ Benraad, AGH Smals The Journal of Steroid Biochemistry and Molecular Biology 58 (3), 319-324, 1996 | 21 | 1996 |
| 4 Seeberger KL, Dufour JM, Shapiro AM, Lakey JR RV Rajotte, GS Korbutt, R Dressel, J Gromoll, W Engel, ET Waas, T Feuth, ... Laboratory Investigation 87, 10-13, 2007 | | 2007 |
| 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer T De Marchi, NQ Liu, C Stingl, MA Timmermans, M Smid, MP Look, ... Molecular oncology 10 (1), 24-39, 2016 | 40 | 2016 |
| 4-protein signature predicts outcome to tamoxifen treatment in estrogen receptor positive recurrent breast cancer TD Marchi, NQ Liu, M Tjoa, C Stingl, M Smid, MP Look, MA Timmermans, ... Cancer Research 74 (19_Supplement), 1611-1611, 2014 | | 2014 |
| 44 INVOLVEMENT OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN LARYNGEAL CANCER PATIENTS TREATED WITH HYPOXIA MODIFICATION AS AN ADDITIVE TO ACCELERATED RADIOTHERAPY MM Nijkamp, PN Span, IJ Hoogsteen, CHJ Terhaard, PAH Doornaert, ... Radiotherapy and Oncology, S15, 2012 | | 2012 |
| 58 DIFFERENCES IN METABOLISM BETWEEN ADENO-AND SQUAMOUS CELL NON-SMALL CELL LUNG CARCINOMAS ACCORDING TO GLUT1 AND MCT4 EXPRESSION TWH Meijer, OCJ Schuurbiers, MG Looijen-Salamon, PN Span, J Bussink Radiotherapy and Oncology, S20, 2012 | | 2012 |
| 61 EFFECTS OF EGFR-INHIBITION AND RADIOTHERAPY ON HYPOXIA, PROLIFERATION AND TUMOR GROWTH DELAY IN HUMAN TUMOR XENOGRAFTS H Stegeman, P Span, AJ van der Kogel, D Wheeler, J Kaanders, ... Radiotherapy and Oncology, S21, 2012 | | 2012 |
| A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer A Eustace, N Mani, PN Span, JJ Irlam, J Taylor, GNJ Betts, H Denley, ... Clinical cancer research 19 (17), 4879-4888, 2013 | 255 | 2013 |
| A Novel Non-Invasive Short Synacthen Test Validated in a Healthy Paediatric Population C Elder, R Vilela, T Johnson, EH Kemp, B Keevil, J Newell-Price, R Ross, ... HORMONE RESEARCH IN PAEDIATRICS 90, 27-27, 2018 | | 2018 |
| A prospective randomized trial evaluating tissue effects of finasteride therapy in benign prostatic hyperplasia MR Feneley, PN Span, JA Schalken, M Harper, K Griffiths, K Holmes, ... Prostate cancer and prostatic diseases 2 (5), 277-281, 1999 | 26 | 1999 |
| Aberrant apobec3b expression in breast cancer is linked to proliferation and cell cycle phase PA Roelofs, MAM Timmermans, B Stefanovska, MA den Boestert, ... Cells 12 (8), 1185, 2023 | 6 | 2023 |
| Abstract LB-118: High APOBEC3B mRNA levels in estrogen receptor-positive primary tumors predict short time to progression for hormone-naive breast cancer patients treated with … AM Sieuwerts, ME Meijer-van Gelder, FCGJ Sweep, PN Span, ... Cancer Research 75 (15_Supplement), LB-118-LB-118, 2015 | | 2015 |
| Abstract P264: Targeting oxygen metabolism reduces hypoxia in the tumor microenvironment of a syngeneic mouse model DF Boreel, P Span, H Peters, RJE van den Bijgaart, S Heskamp, ... Molecular Cancer Therapeutics 20 (12_Supplement), P264-P264, 2021 | 2 | 2021 |
| Abstract P3-06-01: Hotspot mutations in PIK3CA are predictive for treatment outcome on aromatase inhibitors but not for tamoxifen ADE Ramirez, JC Helmijr, I Lurkin, M Look, K Ruigrok-Ritstier, I Simon, ... Cancer Research 72 (24_Supplement), P3-06-01-P3-06-01, 2012 | | 2012 |
